Back to Supplement Score

Supplements for gut health

Evidence-based picks for IBS, constipation, post-antibiotic recovery, and general gut function — dietary diversity is the highest-leverage intervention; supplements are adjuncts.

The gut microbiome is the most-marketed and most-misunderstood corner of the supplement aisle. Two truths: (1) dietary diversity — particularly variety of plant fibre — produces the largest measurable changes in microbiome composition and diversity, and outperforms any probiotic supplement on this dimension; (2) strain-specific probiotics have real but narrow evidence for specific indications (post-antibiotic diarrhea, IBS, infant colic, antibiotic-associated CDI risk). The framing here is "specific strains for specific conditions" — not "probiotic = good." The bundled "gut health" formulas at premium prices typically deliver under-dosed strains with no condition-specific evidence.

Psyllium husk (soluble fibre)

Constipation · IBS-C · Lipids · Glucose

Tier 1

Peppermint oil (enteric-coated)

IBS pain · Smooth muscle relaxation

Tier 1

Lactobacillus rhamnosus GG

Antibiotic-associated diarrhea · Pediatric AAD

Tier 1

Saccharomyces boulardii

AAD · CDI prevention · Traveler's diarrhea

Tier 1

Partially hydrolysed guar gum (PHGG)

IBS · Mixed bowel pattern · Low-FODMAP friendly

Tier 2

Bifidobacterium longum BB536

Constipation · Gut barrier · Immune adjunct

Tier 2

Lactobacillus plantarum 299v

IBS bloating · Iron absorption adjunct

Tier 2

Vitamin D3

Immune modulation · IBD adjunct evidence · Common deficiency in gut disease

Tier 1

The gut-health stack — rationale by ingredient

Psyllium husk 5–10 g/day with water (general gut health and IBS-C)

The most-evidenced fibre supplement. Soluble fibre supports stool form, bowel regularity, glycaemic stability, and cholesterol lowering. FDA-recognised health claim. Titrate up from low doses to manage initial bloating.

Peppermint oil (enteric-coated) 180–225 mg × 2–3/day for IBS pain

The supplement with the cleanest IBS-pain trial evidence — multiple meta-analyses show benefit. Enteric coating is essential to deliver active to the small intestine and avoid heartburn from gastric release.

Lactobacillus rhamnosus GG during and after antibiotics

The strain with the best evidence for preventing antibiotic-associated diarrhea, particularly in children. Take during antibiotic course and continue 1–2 weeks post-course. Doses in trials typically 10–20 billion CFU/day.

Saccharomyces boulardii during travel or antibiotics

Yeast (not bacterial) probiotic with strong evidence for traveler's diarrhea prevention and CDI risk reduction during antibiotics. 250–500 mg twice daily.

Partially hydrolysed guar gum (PHGG) 5 g/day for IBS

Soluble fibre with better tolerability in IBS than psyllium for some users; low-FODMAP friendly. Useful in IBS with mixed bowel pattern.

Bifidobacterium longum BB536 for constipation-dominant patterns

Strain with reasonable trial evidence for chronic constipation symptom improvement. Reasonable addition to a fibre baseline.

Lactobacillus plantarum 299v for bloating-dominant IBS

Evidence for bloating reduction and abdominal pain in IBS. Additional adjunct benefit on iron absorption.

Vitamin D3 (test and target)

Low vitamin D is common in IBD and other gut diseases and contributes to systemic immune dysregulation. Test 25-OH-D and supplement to 30–50 ng/mL.

What to skip

Bundled "50-billion CFU multi-strain" formulas — strain identity, dose, and refrigeration matter more than the CFU number; many bundled products are under-dosed on the strains that matter.
Activated charcoal for general "detox" — has clinical use in acute poisoning; chronic supplementation is unsupported and reduces absorption of medications and nutrients.
"Leaky gut" cure-all formulas — "leaky gut syndrome" is poorly defined; the marketed cures (zonulin-binding supplements, "gut-healing" amino acid blends, glutamine megadoses) lack clinical evidence.
Glutamine standalone at high doses for "gut healing" — limited evidence outside specific clinical scenarios (post-chemotherapy mucositis, short-bowel syndrome).
"Colon cleanse" / "parasite cleanse" supplements — typically contain stimulant laxatives plus anthraquinone-containing herbs; cause dependency, electrolyte disturbance, and provide no clinical benefit.
Apple cider vinegar high-dose for "gut acidity" — minimal evidence for gut benefits; esophageal and dental damage at high doses.
Bone broth supplements as "gut healing" — protein content is small; "healing" claim lacks evidence; whole-food bone broth is fine.
Bentonite clay, diatomaceous earth, zeolite — no clinical evidence; potential heavy-metal exposure depending on source.
Premium "personalised microbiome supplement subscriptions" — current at-home microbiome testing is not validated for the personalised recommendations it generates.

Educational reference, not medical advice. New or worsening GI symptoms — change in bowel habits, blood in stool, unintended weight loss, persistent pain, or family history of GI cancer — warrant medical evaluation. Inflammatory bowel disease (Crohn's, ulcerative colitis), celiac disease, microscopic colitis, and other diagnosable conditions should be evaluated before adopting a supplement-only approach. For SIBO and post-infectious IBS, work with a gastroenterologist or dietitian — specific protocols (low-FODMAP, antibiotic eradication, strain-specific probiotics) outperform generic "gut health" stacks.

Sources

Khan KJ, et al. Efficacy of psyllium fibre in irritable bowel syndrome. Am J Gastroenterol. 2014;109(9):1367–1374. PMID: 25070054
Khanna R, et al. Peppermint oil for irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014;48(6):505–512. PMID: 24100754
Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea. Cochrane Database Syst Rev. 2017;12:CD006095. PMID: 29257353
McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5(2):97–105. PMID: 17298915
Hill C, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. PMID: 24912386
McKenzie YA, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of IBS in adults (2016 update). J Hum Nutr Diet. 2016;29(5):549–575. PMID: 27272325